US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 9.020
- +0.545+6.43%
Close Nov 21 16:00 ET
- 9.100
- +0.080+0.89%
Post 20:01 ET
764.86MMarket Cap-17686P/E (TTM)
9.390High8.230Low1.52MVolume8.490Open8.475Pre Close13.72MTurnover1.85%Turnover RatioLossP/E (Static)84.80MShares10.45052wk High5.89P/B741.50MFloat Cap3.25052wk Low--Dividend TTM82.21MShs Float31.500Historical High--Div YieldTTM13.69%Amplitude0.600Historical Low9.009Avg Price1Lot Size
Anavex Life Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -10.37%138.76M | -9.18%139.39M | 0.10%143.77M | 1.25%151.02M | 1.25%151.02M | 1.06%154.82M | 0.08%153.47M | -4.98%143.62M | -1.94%149.16M | -1.94%149.16M |
| -Cash and cash equivalents | -10.37%138.76M | -9.18%139.39M | 0.10%143.77M | 1.25%151.02M | 1.25%151.02M | 1.06%154.82M | 0.08%153.47M | -4.98%143.62M | -1.94%149.16M | -1.94%149.16M |
| Receivables | -20.56%1.72M | -20.11%3.79M | -13.32%3.55M | -15.16%2.71M | -15.16%2.71M | -66.99%2.17M | -26.76%4.74M | -23.78%4.09M | -65.05%3.19M | -65.05%3.19M |
| -Taxes receivable | -20.56%1.72M | -20.11%3.79M | -13.32%3.55M | -15.16%2.71M | -15.16%2.71M | -66.99%2.17M | -26.76%4.74M | -23.78%4.09M | -65.05%3.19M | -65.05%3.19M |
| Other current assets | 27.96%1.06M | 37.00%1.35M | 15.31%756K | 84.46%653K | 84.46%653K | 79.14%827.57K | 111.31%981.77K | 73.51%655.64K | -4.82%354K | -4.82%354K |
| Total current assets | -10.31%141.54M | -9.22%144.52M | -0.20%148.07M | 1.10%154.39M | 1.10%154.39M | -1.50%157.81M | -0.68%159.19M | -5.43%148.37M | -5.51%152.71M | -5.51%152.71M |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -10.31%141.54M | -9.22%144.52M | -0.20%148.07M | 1.10%154.39M | 1.10%154.39M | -1.50%157.81M | -0.68%159.19M | -5.43%148.37M | -5.51%152.71M | -5.51%152.71M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -15.65%3.5M | -40.69%3.73M | -18.84%4.29M | 12.99%4.32M | 12.99%4.32M | 32.81%4.15M | 138.68%6.28M | 14.10%5.29M | -19.30%3.83M | -19.30%3.83M |
| -accounts payable | -15.65%3.5M | -40.69%3.73M | -18.84%4.29M | 12.99%4.32M | 12.99%4.32M | 32.81%4.15M | 138.68%6.28M | 14.10%5.29M | -19.30%3.83M | -19.30%3.83M |
| Current accrued expenses | 25.24%6.3M | -18.39%4.29M | -5.05%5.5M | 27.72%5.94M | 27.72%5.94M | 0.18%5.03M | 17.09%5.25M | 36.49%5.79M | 5.31%4.65M | 5.31%4.65M |
| Current deferred liabilities | 0.03%917K | 0.03%917K | 0.03%917K | 106.53%917K | 106.53%917K | 106.56%916.76K | 106.56%916.76K | 106.56%916.76K | 0.04%444K | 0.04%444K |
| Current liabilities | 6.32%11.75M | -31.83%9.56M | -5.68%12.5M | 22.71%12.53M | 22.71%12.53M | 16.56%11.06M | 73.72%14.02M | 25.83%13.25M | -5.41%10.21M | -5.41%10.21M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 6.32%11.75M | -31.83%9.56M | -5.68%12.5M | 22.71%12.53M | 22.71%12.53M | 16.56%11.06M | 73.72%14.02M | 25.83%13.25M | -5.41%10.21M | -5.41%10.21M |
| Shareholders'equity | ||||||||||
| Share capital | 4.43%85K | 4.69%84K | 5.08%82K | 5.13%82K | 5.13%82K | 4.42%81.39K | 3.98%80.24K | 2.46%78.03K | 2.74%78K | 2.74%78K |
| -common stock | 4.43%85K | 4.69%84K | 5.08%82K | 5.13%82K | 5.13%82K | 4.42%81.39K | 3.98%80.24K | 2.46%78.03K | 2.74%78K | 2.74%78K |
| -Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Retained earnings | -14.68%-324.45M | -14.94%-312.24M | -16.69%-301.69M | -19.35%-293.07M | -19.35%-293.07M | -22.33%-282.92M | -24.09%-271.64M | -24.02%-258.54M | -24.28%-245.56M | -24.28%-245.56M |
| Paid-in capital | 5.74%454.24M | 7.35%447.35M | 11.08%437.18M | 12.08%434.84M | 12.08%434.84M | 12.48%429.6M | 12.19%416.73M | 10.94%393.58M | 11.38%387.98M | 11.38%387.98M |
| Other equity interest | ---89K | ---234K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | -11.57%129.78M | -7.03%134.96M | 0.33%135.58M | -0.45%141.85M | -0.45%141.85M | -2.64%146.75M | -4.63%145.17M | -7.68%135.12M | -5.52%142.49M | -5.52%142.49M |
| Total equity | -11.57%129.78M | -7.03%134.96M | 0.33%135.58M | -0.45%141.85M | -0.45%141.85M | -2.64%146.75M | -4.63%145.17M | -7.68%135.12M | -5.52%142.49M | -5.52%142.49M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data